Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.930
-0.000 (-0.02%)
At close: Apr 28, 2026, 4:00 PM EDT
0.948
+0.019 (1.99%)
After-hours: Apr 28, 2026, 7:21 PM EDT
Jasper Therapeutics Employees
Jasper Therapeutics had 22 employees as of December 31, 2025. The number of employees decreased by 42 or -65.63% compared to the previous year.
Employees
22
Change (1Y)
-42
Growth (1Y)
-65.63%
Revenue / Employee
n/a
Profits / Employee
-$3,445,500
Market Cap
26.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22 | -42 | -65.63% |
| Dec 31, 2024 | 64 | 19 | 42.22% |
| Dec 31, 2023 | 45 | 10 | 28.57% |
| Dec 31, 2022 | 35 | 10 | 40.00% |
| Dec 31, 2021 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Quince Therapeutics | 38 |
| Curis | 24 |
| OSR Holdings | 22 |
| Serina Therapeutics | 13 |
| VYNE Therapeutics | 10 |
| Exicure | 8 |
| Lexaria Bioscience | 7 |
JSPR News
- 4 weeks ago - Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Jasper Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference - GlobeNewsWire
- 3 months ago - Jasper Therapeutics Transcript: Study Result - Transcripts
- 3 months ago - Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria - GlobeNewsWire
- 3 months ago - Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth - GlobeNewsWire
- 5 months ago - Jasper Therapeutics Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts
- 5 months ago - Jasper Therapeutics Transcript: Study Result - Transcripts